Postmortem studies have documented degeneration of dopamine cells with
age, but the changes that occur in healthy aging individuals is less
clear. The purpose of this study was to evaluate the extent to which a
ge-induced changes in dopamine transporters occur in subjects with no
evidence of motor impairment. Methods: We evaluated 23 right-handed he
althy volunteers (age range 20-74 yr) using PET and [C-11]d-threo-meth
ylphenidate. The ratio of the distribution volume for [C-11]d-threo-me
thylphenidate in striatum to that in cerebellum was used as model para
meter for dopamine transporter availability (Bmax/Kd + 1). Results: Do
pamine transporter availability was significantly lower in subjects >4
0 yr of age than in those <40 yr. Estimates of dopamine transporter av
ailability showed a significant negative correlation with age both for
the putamen (r = -0.72, p < 0.0001) and the caudate (r = -0.74, p < 0
.0001). Dopamine transporter availability was higher in the left than
in the right putamen but did not differ between the left and right cau
date. Conclusion: This study documents a 6.6% decrease per decade of l
ife in striatal dopamine transporters of healthy volunteers.